Search
Searching Evidence for "Celery seed" · search everything instead
Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.
1 study records (showing up to 30 per record type)
-
Systematic review registration CRD42021285801 Registered protocol, no results here: Review OngoingEffect of Butylphthalide on Circulating Levels of Inflammatory Markers in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled TrialsCondition or outcome area: Acute ischemic cerebral apoplexy is the most common type of cerebral apoplexy in clinic. The disease is ischemic hypoxic necrosis of brain tissue caused by various reasons of brain tissue blood supply disorders. .The immune response to acute cerebral ischemia is a major factor in stroke pathobiology and outcome. Butylphthalide is a new drug developed by China. Its main active ingredient is extracted from celery seed. Its effect is to increase the number of capillaries in ischemic brain area, im2021-11-17 · Subject: Butylphthalide; 6066-49-5; 3-n-Butylphthalide; 3-BUTYLPHTHALIDE; 3-butylisobenzofuran-1(3H)-one; Phthalide, 3-butyl-; 1(3H)-Isobenzofuranone, 3-butyl-; 3-N-BUTYLPHATHLIDE; 3-Butyl-1(3H)-isobenzofuranone; FEMA No. 3334 · open the ingredient record